A laboratory model to explain the survival advantage observed in patients taking adjuvant tamoxifen therapy.
Wolf
D M
DM
Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, Madison 53792.
Jordan
V C
VC
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008954:Models, Biological; D009364:Neoplasm Recurrence, Local; D015996:Survival Rate; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen